ClinConnect ClinConnect Logo
Search / Trial NCT00655213

Spontaneous Atrio Ventricular Conduction Preservation

Launched by LIVANOVA · Apr 3, 2008

Trial Information

Current as of May 06, 2025

Completed

Keywords

Pacing, Av Conduction Disorders, Minimized Ventricular Pacing, Af

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient has been primo-implanted with a Symphony™ 2550 or 2450 devices for less than 3 months
  • Patient with a normal spontaneous AV conduction at rest (PR \< 250 ms)
  • Patient implanted for Sinus Node Dysfunction, Braycardia-Tachycardia Syndrome, carotid sinus syndrome/ vaso vagal syndrome or paroxistic AV Block
  • Patient implanted with a bipolar right-atrial lead and ventricular lead available in the local market
  • Patient has signed a consent form after having received the appropriate information
  • Exclusion Criteria:
  • Permanent 1st, 2nd or 3rd AV block
  • Patient having a medical status complying with one of the following cases
  • patient suffering from sustained ventricular arrhythmias
  • patient having sustained a myocardial infarction within the last month
  • patient having undergone cardiac surgery within the last month
  • patient suffering from severe aortic stenosis
  • patient suffering from unstable angina pectoris
  • patient presents with permanent atrial arrhythmias
  • Patient is not able to understand the study objectives and protocol or refuses to co-operate
  • Patient is not available for scheduled follow-up
  • Patient has a life expectancy less than one year
  • Patient is included into another clinical study
  • Patient is minor or a pregnant woman

About Livanova

Livanova is a global medical technology company specializing in innovative solutions for the treatment of neurological and cardiovascular diseases. With a commitment to advancing patient care, Livanova develops cutting-edge devices and therapies that enhance the quality of life for individuals suffering from complex medical conditions. The company focuses on research and development, collaborating with healthcare professionals and institutions to conduct clinical trials that validate the safety and efficacy of its products. Livanova's dedication to innovation is driven by a passion for transforming healthcare through technology, ultimately aiming to improve outcomes for patients worldwide.

Locations

Leeds, , United Kingdom

Nantes, , France

Besancon, , France

Birmingham, , United Kingdom

Lübeck, , Germany

Bristol, , United Kingdom

Aalst, , Belgium

Hull, , United Kingdom

Rennes, , France

Albi, , France

Angers, , France

Grenoble, , France

Paris Cedex 16, , France

Rouen, , France

Vandoeuvre Les Nancy, , France

Munchen, , Germany

Baudour, , Belgium

Bruxelles, , Belgium

Campus St. Elisabeth Uccle, , Belgium

Moen, , Belgium

Montigny Le Tilleul, , Belgium

Tivoli, , Belgium

Aix En Provence, , France

Castres Mazamet, , France

Clermont Ferrand, , France

Lille, , France

Limoges, , France

Montpellier, , France

Mulhouse, , France

Nantes, , France

Nice, , France

St Cloud, , France

Bonn, , Germany

Bonn, , Germany

Bremen, , Germany

Halberstadt, , Germany

Holzminden, , Germany

Hürth, , Germany

Kassel, , Germany

Koln, , Germany

Luedenscheid, , Germany

Lüneburg, , Germany

Mainz, , Germany

Marburg, , Germany

Memmingen, , Germany

Munchen, , Germany

Munchen, , Germany

Peine, , Germany

Regensburg, , Germany

Starnberg, , Germany

Ulm, , Germany

Waren, , Germany

Wolgast, , Germany

Avellino, , Italy

Chiari (Bs), , Italy

Conegliano (Tv), , Italy

Foligno (Pg), , Italy

Mestre (Ve), , Italy

Portogruaro (Ve), , Italy

San Donato, , Italy

Sesto S. Giovanni (Mi), , Italy

Trento, , Italy

Venezia, , Italy

Voghera, , Italy

Burton On Trent, , United Kingdom

London, , United Kingdom

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Jean Marc DAVY, PhD

Principal Investigator

CH Montpellier

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials